Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleContinuing Education

PET in Lung Cancer

R. Edward Coleman
Journal of Nuclear Medicine May 1999, 40 (5) 814-820;
R. Edward Coleman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 5
May 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET in Lung Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET in Lung Cancer
R. Edward Coleman
Journal of Nuclear Medicine May 1999, 40 (5) 814-820;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET in Lung Cancer
R. Edward Coleman
Journal of Nuclear Medicine May 1999, 40 (5) 814-820;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Use of Pre-treatment 18F-FAMT PET to Predict Patient Survival in Squamous Cell Carcinoma of the Esophagus Treated by Curative Surgery
  • L-[3-18F]-{alpha}-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer
  • Molecular MRI for sensitive and specific detection of lung metastases
  • The role of positron emission tomography in the management of non-small cell lung cancer
  • ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
  • Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT
  • Utility of 18F-FDG PET in Evaluating Cancers of Lung
  • Detection of Unexpected Additional Primary Malignancies with PET/CT
  • Diagnostic Value and Limitations of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Cartilaginous Tumors of Bone
  • 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
  • Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non-Small-Cell Lung Cancer
  • The Impact of PET on the Management of Lung Cancer: The Referring Physician's Perspective
  • Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
  • 18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in Staging Newly Diagnosed Non-Small Cell Lung Cancer
  • The Utility of 18F-FDG PET for Suspected Recurrent Non-Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
  • Comparison of [18F]FDG PET and 201Tl SPECT in Evaluation of Pulmonary Nodules
  • Clinical Skills in Conducting Research Studies on Clinical Applications of Oncologic PET
  • Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
  • Performance of a Dual, Solid-State Intraoperative Probe System with 18F, 99mTc, and 111In
  • Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology
  • Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non-Small-Cell Lung Cancer: A Prospective Study
  • Google Scholar

More in this TOC Section

  • From Concept to Regulatory Drug Approval: Lessons for Theranostics
  • Oligometastatic Prostate Cancer: Current Status and Future Challenges
  • Dosimetry in Radiopharmaceutical Therapy
Show more Continuing Education

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire